Hostname: page-component-77c89778f8-vpsfw Total loading time: 0 Render date: 2024-07-19T09:35:47.710Z Has data issue: false hasContentIssue false
  • English
  • Français

Effects of luxabendazole on the tegument of Fasciola hepatica

Published online by Cambridge University Press:  05 June 2009

S.R. Stoitsova  and
L.N. Gorchilova
S.R. Stoitsova
Affiliation:
Institute of Parasitology, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., Bl. 25, 1113 Sofia, Bulgaria
L.N. Gorchilova
Affiliation:
Institute of Parasitology, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., Bl. 25, 1113 Sofia, Bulgaria
Get access Rights & Permissions [Opens in a new window]

Abstract

The effects in vivo of 5, 10, and 20 mg/kg of luxabendazole (LBZ) on the tegument of Fasciola hepatica have been examined 48 h, 7 days and 14 days post-treatment of experimentally-infected rats. As early as 48 h post-treatment, the drug is shown to provoke significant damage to the tegument. The pathological phenomena characterizing LBZ damage are blebbing of the apical plasmalemma, formation of microvillus-like projections over the free surface, swelling of the basal infolds and stimulation of autophagy. The spines are often fractured; the tegument in the vicinity of spines seems more strongly altered than that in other foci. The basal layer is often changed, from increase of electron density to lack of integrity with the apical cytoplasm. The progress of the ultrastructural damage with time is not expressed. However, cytochemical data show that at longer post-treatment intervals the surface-coat structure becomes irregular and patches of ruthenium red positive material of variable thickness are focally accumulated. Only a slight dose-effect is noted 48 h after LBZ application when the alterations provoked by 5 mg/kg are less evident than those by 10 and 20 mg/kg.

Type
Research Papers
Information
Journal of Helminthology , Volume 68 , Issue 1 , March 1994 , pp. 73 - 80
Copyright
Copyright © Cambridge University Press 1994

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Anderson, H.R. & Fairweather, I. (1988) Fasciola hepatica: Scanning electron microscopic observations of juvenile flukes following treatment in vitro with the deacetylated (amine) metabolite of diamphenethide (DAMD). International Journal for Parasitology 18, 827–837.CrossRefGoogle ScholarPubMed
Borgers, M., De Nollin, S., De Brabander, M. & Thienpont, D. (1975a) Influence of the anthelmintic mebendazole on microtubules and intracellular organelle movement in nematode intestinal cells. American Journal of Veterinary Research 36, 1153–1166.Google ScholarPubMed
Borgers, M., De Nollin, S., Verheyen, A., Vanparijs, O. & Thienpont, D. (1975b) Morphological changes in cysticerci of Taenia taeniaeformis after mebendazole treatment. Journal of Parasitology 61, 830–843.CrossRefGoogle ScholarPubMed
Čorba, J., Hovorka, J., Špaldonova, R., Stoffa, P. & Legeny, J. (1987) Efficacy of luxabendazole (Hoe 216 V) susp. 5% in sheep naturally infected with the most important helminths. Helminthologia 24, 227–235.Google Scholar
Criado-Fornelio, A., Armas-Serra, C., de Jimenez-Gonzalez, A., Casado-Escribano, N. & Rodriguez-Caabeiro, F. (1990) Biochemical effects of luxabendazole on Trichinella spiralis. Parasitology Research 76, 518–520.CrossRefGoogle ScholarPubMed
Delatour, P. & Benoit, E. (1988) Metabolisme, mode d'action et pharmacocinetique des anthelmintiques chez les ruminants. Revue de Medicine Veterinaire 139, 47–52.Google Scholar
Düvel, D. (1990) Luxabendazol – ein neues Breitspekurmm Anthelminthikum fur Shafe und Wildtiere. pp. 14–18 in Gores, E. (Ed.) Medicamentum Informationen für Arzte und Apotheker. Berlin, VEB Verlage für Medizin und Biologie.Google Scholar
Fairweather, I., Anderson, H.R. & Baldwin, T.M.A. (1987) Fasciola hepatica: tegumental surface alterations following treatment in vitro with deacetylated (amine) metabolite of diamphenethide. Parasitology Research 73, 99–106.CrossRefGoogle ScholarPubMed
Gorchilova, L.N. (1980) (Comparative morphofunctional characteristics of the tegument and the intestinal wall of juvenile and adult Fasciola hepatica.) PhD Thesis, Central Laboratory of Helminthology, Sofia.Google Scholar
Gorchilova, L. & Poljakova-Krusteva, O. (1985) Electronmicroscopical and enzymocytochemical investigations on the effect of dertil (meniclopholan) on the tegument and the gut wall of sexually mature Fasciola hepatica. Khelmintologiya 19, 11–24.Google Scholar
Gorchilova, L., špaldonova, R. & Poljakova-Krusteva, O. (1988) Morphofunctional characteristics of the tegument and the gut wall of mature Fasciola hepatica after fenbendazole/triclabendazole treatment. Helminthologia 25, 147–155.Google Scholar
Gorchilova, L., Georgieva, D., Svilenov, D. & Dacheva, R.(1990a) Morphofunctional changes in experimental ovine cysticercosis after mebendazole treatment. Comptes Rendus de l'Académie Bulgare des Sciences 43, 103–106.Google Scholar
Gorchilova, L., Poljakova-Krusteva, O., špaldonova, R. & Vinarova, M. (1990b) Structural and functional characteristics of the tegument and intestinal wall in mature Fasciola hepatica after treatment with luxabendazole. Helminthologia 27, 79–80.Google Scholar
Gorchilova, L., Poljakova-Krusteva, O., Stoitsova, S. & Danek, J. (1991) Morphofunctional changes in the tegument and intestinal wall of adult Fasciola hepatica under the action of oxyclosanide and VUFB 15 269. Helminthologia 28, 67–74.Google Scholar
Hamajima, F., Fujino, T., Yamagami, K. & Eriguchi, N. (1979) Studies on the in vitro effects of bithionol and meniclopholan on flukes of Clonorchis sinensis, Metagonimus takahashii and Paragonimus miyazakii. International Journal for Parasitology 9, 241–249.CrossRefGoogle ScholarPubMed
Kassai, T., Takats, C., Fok, E. & Redl, P. (1988) Activity of luxabendazole against liver flukes, gastrointestinal round- worms, and lungworms in naturally infected sheep. Parasitology Research 75, 14–8.CrossRefGoogle Scholar
Lacey, E. (1989) Comparative biochemistry of parasites and its role in drug resistance— an investigation of species differences in tubulin. pp. 145–67 in Bennett, E.M., Behm, C. & Bryant, C. (Eds) Comparative biochemistry of parasitic helrninths. London & New York, Chapman and Hall.Google Scholar
Luft, J.H. (1971) Ruthenium red and violet. I. Chemistry, purification, methods for use for electron microscopy and mechanisms of action. Anatomical Record 171, 347–368.CrossRefGoogle Scholar
Poljakova-Krusteva, O.T., Gorchilova, L.N., Mizinska-Boevska, Ya.D. & Stoitsova, S.R. (1985) Lysosomes and lysosome-like structures in the teguments of trematodes and cestodes. Khelmintologiya 26, 66–79.Google Scholar
Rew, R.S., Fetterer, R.H. & Martin, T.C. (1983) Fasciola hepatica: Effects of diamphenetide free amine on in vitro physiology, biochemistry, and morphology. Experimental Parasitology 55, 159–167.CrossRefGoogle Scholar
Skuce, P.J. & Fairweather, I. (1989) Fasciola hepatica: the effect of the sodium ionophore monensin on the adult tegument. Parasitology Research 75, 223–232.CrossRefGoogle ScholarPubMed
Skuce, P.J., Anderson, H.R. & Fairweather, I. (1987) The interaction between the deacetylated (amine) metabolite of diamphenethide (DAMD) and cytochemically demonstrable Na+/K+-ATPase activity in the tegument of Fasciola hepatica. Parasitology Research 74, 161–167.CrossRefGoogle ScholarPubMed
Stitt, A.W., Fairweather, L, Trudgett, A.G., Johnston, C.F. & Anderson, S.M.L. (1992a) Localization of actin in the liver fluke, Fasciola hepatica. Parasitology Research 78, 96–102.CrossRefGoogle ScholarPubMed
Stitt, A.W., Fairweather, I., Trudgett, A.G. & Johnston, C.F. (1992b) Fasciola hepatica: localization and partial characterization of tubulin. Parasitology Research 78, 102–127.CrossRefGoogle ScholarPubMed
Stoitsova, S.R., Gorchilova, L.N. & Danek, J. (1992) Effects of three anthelmintics on the tegument of Hymenolepis fraterna (Cestoda). Parasitology 104, 143–152.CrossRefGoogle ScholarPubMed
Stoitsova, S., Poljakova-Krusteva, O. & Vinarova, M. (1991) Fasciola hepatica: a cytochemical study of tegumental blebs. apical vesicles and infolds and their possible relation to surface membrane shedding. Helminthologia 28, 5–11.Google Scholar
Stoitsova, S.R., Vinarova, M.I. & Poljakova-Krusteva, O. T.(1992) Diethylnitrosamine-provoked surface coat changes of Fasciola hepatica. Comptes Rendus de l'Acadérmie Bulgare des Sciences 45, 127–129.Google Scholar
Taraschewski, H., Mehlhorn, H., Bunnag, D., Andrews, P. & Thomas, H. (1986) Effects of praziquantel on human intestinal flukes (Fasciolopsis buski and Heterophyes heterophyes). Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene A262, 542–550.Google Scholar
Threadgold, L.T. (1976) Fasciola hepatica: Ultrastructure and cytochemistry of the glycocalyx of the tegument. Experimental Parasitology 39, 119–134.CrossRefGoogle ScholarPubMed
Threadgold, L.T. (1985) Fasciola hepatica; Interaction of the tegument with poly-L-lysine and enzymes. Experimental Parasitology 59, 222–230.CrossRefGoogle ScholarPubMed
Threadgold, L.T. & Brennan, C. (1978) Fasciola hepatica: Basal infolds and associated vacuoles of the tegument. Experimental Parasitology 46, 300–316.CrossRefGoogle ScholarPubMed
Verheyen, A. (1982) Echinococcus granulosus: The influence of mebendazole therapy on the ultrastructural morphology of the germinal layer of hydatid cysts in humans and mice. Zeitschrift für Parasitenkunde 67, 55–65.CrossRefGoogle Scholar
Verheyen, A., Borgers, M., Vanparijs, O. & Thienpont, D. (1978) The effects of mebendazole on the ultrastructure of cestodes. pp. 605–618in Van den Bossche, H. (Ed.) Biochemistry of parasites and host-parasite relationships. Amsterdam, Elsevier/North Holland Biomedical Press.Google Scholar
Von Malottki, A., Daugschies, A., Ising, S. & Stoye, M. (1990) Zur Wirkung von Luxabendazol gegen Helminthen beim Schaf. Der Praktische Tierarzt 8, 52–54.Google Scholar
Watts, S.D.M., Orpin, A. & MacCormick, C. (1979) Lysosomes and tegumental pathology in the therapy of schistosomiasis with 1, 7-bis(p-aminophenoxy)heptane (153C51). Parasitology 78, 287–294.CrossRefGoogle Scholar